Okta, Inc. vs Biogen Inc.
μκ°μ λ°λ₯Έ μκ°μ΄μ‘ λΉκ΅
Okta, Inc.
$35.6B
μμ #291
Biogen Inc.
$37.0B
μμ #287
μκ°μ λ°λ₯Έ μκ°μ΄μ‘
μ£Όμ μκ°
- Okta, Inc.μ΄(κ°) 2020λ κΉμ§ Biogen Inc.μ(λ₯Ό) μΆμνμ΅λλ€
- Biogen Inc.μ΄(κ°) 2022λ κΉμ§ Okta, Inc.μ(λ₯Ό) μΆμνμ΅λλ€
μ°λλ³ λΉκ΅
| μ°λ | Okta, Inc. | Biogen Inc. | μ λ |
|---|---|---|---|
| 2026 | $35.6B | $37.0B | Biogen Inc. |
| 2025 | $14.4B | $26.0B | Biogen Inc. |
| 2024 | $13.1B | $22.6B | Biogen Inc. |
| 2023 | $15.0B | $38.2B | Biogen Inc. |
| 2022 | $11.4B | $40.9B | Biogen Inc. |
| 2021 | $37.2B | $35.4B | Okta, Inc. |
| 2020 | $42.2B | $36.2B | Okta, Inc. |
| 2019 | $19.2B | $43.8B | Biogen Inc. |
| 2018 | $10.6B | $44.4B | Biogen Inc. |
| 2017 | $4.3B | $47.0B | Biogen Inc. |